Evidence map›Paper›PMID 33574448›Full record

ArticleScientific reports2021

Radiomics signature on CECT as a predictive factor for invasiveness of lung adenocarcinoma manifesting as subcentimeter ground glass nodules.

Wufei Chen, Ming Li, Dingbiao Mao, Xiaojun Ge, Jiaofeng Wang, Mingyu Tan, Weiling Ma, Xuemei Huang, Jinjuan Lu, Cheng Li and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Wufei ChenDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Ming Li *Department of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China. minli77@163.com.
Dingbiao MaoDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Xiaojun GeDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Jiaofeng WangDepartment of Science and Education, Huadong Hospital Affiliated To Fudan University, 168 West Yan'an Road, Shanghai, 200040, China.
Mingyu TanDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Weiling MaDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Xuemei HuangDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Jinjuan LuDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Cheng LiDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Yanqing Hua *Department of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Hao WuDepartment of Radiology, Huadong Hospital Affiliated To Fudan University, 221 West Yan'an Road, Shanghai, 200040, China.
Fudan University · CNHuadong Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controversy and challenges remain regarding the cognition of lung adenocarcinomas presented as subcentimeter ground glass nodules (GGNs). Postoperative lymphatic involvement or intrapulmonary metastasis is found in approximately 15% to 20% of these cases. This study aimed to develop and validate a radiomics signature to identify the invasiveness of lung adenocarcinoma appearing as subcentimeter ground glass nodules. We retrospectively enrolled 318 subcentimeter GGNs with histopathology-confirmed adenocarcinomas in situ (AIS), minimally invasive adenocarcinomas (MIA) and invasive adenocarcinomas (IAC). The radiomics features were extracted from manual segmentation based on contrast-enhanced CT (CECT) and non-contrast enhanced CT (NCECT) images after imaging preprocessing. The Lasso algorithm was applied to construct radiomics signatures. The predictive performance of radiomics models was evaluated by receiver operating characteristic (ROC) analysis. A radiographic-radiomics combined nomogram was developed to evaluate its clinical utility. The radiomics signature on CECT (AUC: 0.896 [95% CI 0.815-0.977]) performed better than the radiomics signature on NCECT data (AUC: 0.851[95% CI 0.712-0.989]) in the validation set. An individualized prediction nomogram was developed using radiomics model on CECT and radiographic model including type, shape and vascular change. The C index of the nomogram was 0.915 in the training set and 0.881 in the validation set, demonstrating good discrimination. Decision curve analysis (DCA) revealed that the proposed model was clinically useful. The radiomics signature built on CECT could provide additional benefit to promote the preoperative prediction of invasiveness in patients with subcentimeter lung adenocarcinomas.

Indexed as

Tomography, X-Ray ComputedAdenocarcinoma of LungCalibrationClinical Decision-MakingContrast MediaDiagnosis, DifferentialFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm InvasivenessNomogramsReproducibility of ResultsROC CurveContrast Media

Identifiers

PMID33574448
PMCPMC7878798
OpenAlexW3126486069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.